​

Kyverna Therapeutics Ownership | Who Owns Kyverna Therapeutics?


OverviewForecastFinancialsChart

Kyverna Therapeutics Ownership Summary


Kyverna Therapeutics is owned by 57.65% institutional investors, 6.83% insiders, and 35.52% retail investors. Vida ventures advisors is the largest institutional shareholder, holding 10.47% of KYTX shares. MEDICAL BioHealth EUR Acc is the top mutual fund, with 2.85% of its assets in Kyverna Therapeutics shares.

KYTX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockKyverna Therapeutics57.65%6.83%35.52%
SectorHealthcare Stocks 129.40%12.08%-41.48%
IndustryBiotech Stocks 181.71%11.69%-93.40%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vida ventures advisors4.52M10.47%$27.14M
Gilead sciences4.13M6.78%$28.06M
Bain capital life sciences investors3.11M6.60%$26.84M
Aigh capital management3.65M5.99%$24.82M
Blackrock funding, inc. /de3.24M5.32%$22.02M
Deerfield management company, l.p. (series c)2.00M4.24%$17.26M
Vanguard group1.78M4.10%$16.74M
Vanguard capital management2.01M3.30%$13.68M
Price t rowe associates inc /md/1.56M3.30%$13.42M
Balyasny asset management1.13M2.39%$9.71M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Vida ventures advisors4.52M92.41%$27.14M
Caxton12.35K3.02%$83.96K
Propel bio management700.60K2.53%$4.76M
Aigh capital management3.65M2.50%$24.82M
Bain capital life sciences investors3.11M2.42%$26.84M
Gilead sciences4.13M1.92%$28.06M
Catalio capital management, lp586.91K0.65%$3.52M
Mbb public markets i614.48K0.63%$5.30M
Insight group989.05K0.60%$8.54M
Nano cap new millennium growth fund l p90.00K0.44%$612.00K

Top Buyers

HolderShares% AssetsChange
Aigh capital management3.65M2.50%854.20K
Vanguard group1.78M0.00%458.63K
Fmr538.38K0.00%442.33K
Millennium management1.01M0.00%412.14K
Susquehanna group, llp577.60K0.00%338.77K

Top Sellers

HolderShares% AssetsChange
Novo---1.85M
Adage capital partners gp500.00K0.01%-1.17M
Alyeska investment group---600.00K
Rfg advisory---445.20K
Morgan stanley552.25K0.00%-430.06K

New Positions

HolderShares% AssetsChangeValue
Y-intercept (hong kong)114.84K0.02%114.84K$991.08K
Franklin resources78.00K0.00%78.00K$402.46K
Man group53.54K0.00%53.54K$462.08K
Exoduspoint capital management, lp49.01K0.00%49.01K$422.96K
Act capital partners40.00K0.18%40.00K$272.00K

Sold Out

HolderChange
Ifp advisors-16.00
Sbi securities-22.00
Larson financial group-40.00
Rothschild investment-50.00
Advisory services network-86.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2026124-3.13%35,109,425-7.42%571.49%744.23%24-7.69%
Jun 30, 202612810.34%37,929,5708.92%621.88%7122.41%26-27.78%
Mar 31, 202653-50.00%12,294,874-64.00%260.42%30-53.85%12-45.45%
Dec 31, 202562-21.52%14,501,210-36.11%331.21%3921.88%12-53.85%
Sep 30, 2025761.33%22,548,8730.47%521.94%30-26.83%268.33%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
MEDICAL BioHealth EUR Acc1.76M2.85%373.00
Vanguard MStar Total Stk Mkt Idx Invest1.57M2.54%167.76K
Vanguard Total Stock Mkt Idx Inv1.40M2.31%56.30K
Vanguard Morn Total Stk Mkt Idx Investor1.40M2.31%56.30K
iShares Russell 2000 ETF1.08M1.74%-
T. Rowe Price Health Sciences856.80K1.39%-
Fidelity Enhanced Small Cap Core ETF507.05K0.82%1.36K
Fidelity Small Cap Index459.63K0.74%1.28K
Vanguard Institutional Extnd Mkt Idx Tr436.88K0.71%-11.26K
apo Medical Opportunities R368.61K0.60%-

Recent Insider Transactions


DateNameRoleActivityValue
Dec 18, 2025SEIDENBERG BETH C-Buy$1000.00K
Dec 18, 2025Westlake BioPartners Opportunity Fund I, L.P.-Buy$1000.00K
Dec 15, 2025Walker Karen Marie Chief Technology OfficerSell$292.78K
Feb 12, 2024GILEAD SCIENCES, INC.-Buy$20.02M

Insider Transactions Trends


DateBuySell
2026 Q2--
2026 Q1--
2025 Q421
2025 Q2--
2025 Q1--

KYTX Ownership FAQ


Who Owns Kyverna Therapeutics?

Kyverna Therapeutics shareholders are primarily institutional investors at 57.65%, followed by 6.83% insiders and 35.52% retail investors. The average institutional ownership in Kyverna Therapeutics's industry, Biotech Stocks , is 181.71%, which Kyverna Therapeutics falls below.

Who owns the most shares of Kyverna Therapeutics?

Kyverna Therapeutics’s largest shareholders are Vida ventures advisors (4.52M shares, 10.47%), Gilead sciences (4.13M shares, 6.78%), and Bain capital life sciences investors (3.11M shares, 6.60%). Together, they hold 23.84% of Kyverna Therapeutics’s total shares outstanding.

Does Blackrock own Kyverna Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Kyverna Therapeutics.

Who is Kyverna Therapeutics’s biggest shareholder by percentage of total assets invested?

Vida ventures advisors is Kyverna Therapeutics’s biggest shareholder by percentage of total assets invested, with 92.41% of its assets in 4.52M Kyverna Therapeutics shares, valued at 27.14M$.

Who is the top mutual fund holder of Kyverna Therapeutics shares?

MEDICAL BioHealth EUR Acc is the top mutual fund holder of Kyverna Therapeutics shares, with 2.85% of its total shares outstanding invested in 1.76M Kyverna Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools